Affiliation:
1. University of Minnesota
2. Thomas Jefferson University
3. University of Pittsburgh
4. Duke University
5. University of Rochester
6. Samfund
7. American Society of Clinical Oncology
8. Rutgers, The State University of New Jersey
Abstract
Abstract
Purpose
The American Society of Clinical Oncology Cancer Survivorship Committee established a task force to determine which survivorship care services were being denied by public and private payers for coverage and reimbursement.
Methods
A quantitative survey instrument was developed to determine the clinical practice-reported rates of coverage denials for evidence-based cancer survivorship care services. Additionally, qualitative interviews were conducted to understand whether coverage denials were based on payer policies, cost-sharing, or prior authorization.
Results
Of 122 respondents from 50 states, respondents reported that coverage denials were common (“always”, “most of the time,” or “some of the time”) for maintenance therapies, screening for new primary cancers or cancer recurrence. Respondents reported that denials in coverage for maintenance therapies were highest for immunotherapy (41.74%) and maintenance chemotherapy (40.17%). Coverage denials for new primary cancer screenings were highest for Hodgkin lymphoma survivors needing a PET/CT scan (49.04%) and breast cancer survivors at a high-risk of recurrence who needed an MRI (63.46%), respectively. More than half of survey respondents reported denials for symptom management and supportive care services. Fertility services, dental services when indicated, and mental health services were denied “always” or “most of the time” 23.1%, 22.5%, and 12.8%, respectively. Respondents reported they often had a process in place to automatically appeal denials for evidence-based services. The denial process, however, resulted in greater stress for the patient and provider.
Conclusion
Our study demonstrates that additional advocacy with payers is needed to ensure that reimbursement policies are consistent with evidence-based survivorship care services.
Publisher
Research Square Platform LLC
Reference22 articles.
1. Hewitt M GS, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington D.C.: The National Academies Press, 2006.
2. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care;McCabe MS;J Clin Oncol,2013
3. Version 2.2017, NCCN Clinical Practice Guidelines in Oncology;Denlinger CS;J Natl Compr Canc Netw,2017
4. NCCN Guidelines Insights: Breast Cancer, Version 1.2017;Gradishar WJ;Journal of the National Comprehensive Cancer Network: JNCCN,2017
5. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology;Hoppe RT;J Natl Compr Canc Netw,2017